Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
Filing tables
Filing exhibits
HLN similar filings
Filing view
External links
Exhibit 15.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements No. 333-267647 on Form S-8 and No. 333-273103 on Form F-3, of our report dated 11 March 2022 (20 March 2023 as to Note 11), relating to the financial statements of Haleon UK Holdings (No.2) Limited (formerly known as GlaxoSmithKline Consumer Healthcare Holdings (No. 2) Limited) (predecessor to Haleon plc) appearing in this Annual Report on Form 20-F for the year ended December 31, 2023.
| |
/s/ Deloitte LLP | |
| |
London, United Kingdom | |
| |
15 March 2024 | |